Buyerdock is a Software as a Service (SAAS) global discovery platform that allows retail buyers instant access to compliant ready brands through the company's intelligent cloud technology. Buyerdock enables each supplier to upload details like product information, barcodes, images, and pack size on the portal. Retail buyers can then scrutinise all the available information within specific product categories and select the inventory they wish to purchase intuitively. Buyerdock received a mention from the former CEO of Sainsbury's that the former will speed up the buying process from 6 months to under 3 for retail buyers. The company is in talks with the top six UK retailers, such as Tesco, Marks & Spencer, Home Retail Group, Sainsbury's, Asda, and Morrisons. It will use the investment to grow its business and target the approximate 306,000 retail outlets in the UK, of which around 200,000 are independent retailers.
days to go:
Expired
investment:
£121,157
Zentraxa is focused on precision bioengineering to produce peptides with predictable properties tailored towards purpose. The company points out that peptides are amino acids that are the building blocks of certain proteins needed by the skin, like collagen and elastin. It has come out with a synthetic biology platform, Zentide, that designs, produces and tests novel peptides. Zentraxa argues that Zentide can circumvent previously existing bio-design limits imposed by conventional peptide synthesis and produce tailor-made biomaterials for healthcare, personal care and industrial uses. Zentraxa is initially targeting healthcare with its first biomaterial, a debondable adhesive, for use in wound care. The company asserts that the material has other uses such as cosmetics and industrial applications due to its ability to bond strongly while still being easily and painlessly removable. Zentraxa will use the investment to create a portfolio of other biomaterials for licensing to global businesses in the health and industrial sectors via its Zentide platform.
days to go:
Expired
investment:
£1,040,000
Butterwire is a professional research and portfolio analyst platform designed for high conviction low turnover active equity managers. Butterwire's AI web application was launched in June 2018 and is used by all active equity investors aiming to generate higher returns, with faster stock selection, longer investment horizons, lower portfolio risk, and less trading. The application assists active investors with their top 3 challenges: find opportunities, minimise risk, and keep aware. It is built by and for professionals but is accessible to individual investors, too. The company will utilize 10% of the proceeds to operations, 25% to development, 15% to research, 40% to business development, and 10% to administration.
days to go:
Expired
investment:
Withheld
whatimpact is a social impact technology entity that uses AI and specific reporting tools to match charities and social enterprises, termed 'Recipients', with donor companies and grant-makers, termed 'Supporters' to ensure efficiency and transparency in Corporate Social Responsibility (CSR) and grant-making. whatimpact aspires to become a contender in the CSR segment that is estimated to be worth over £76 billion in reputational value to UK corporates. The business has onboarded 20 companies and 120 charities/Social Enterprises in Q1 2021 including EY, Brewin Dolphin, and Engie. whatimpact has a further 500 charities/social enterprises and 45 corporates in the pipeline. Its subscriptions range from £100/month to £2,000/month. It will use the investment to develop its algorithm and datasets, engage in customer acquisition, and build its leadership team.
days to go:
Expired
investment:
£375,002
Edozo goal is to transform data storage, data sharing and workflow efficiency for commercial property professionals.
days to go:
Expired
investment:
£350,000
3DUserNet is an online portal for viewing and collaborating on 3D data projects. Its SaaS platform enables team members in engineering and construction companies to store, view, navigate and collaborate online, through any modern browser or device, without the need for installed software. The company has been working with sectors such as surveying, policing, civil engineering, security, road safety, and defence. Since its inception, it has added multiple measurement tools including clip boxes, line of sight, checkpoint tool, and slope tool on its platform. The company is seeking an investment of up to £400,000, at a pre-money valuation of £1.6 million under which it is offering investors making up the first £200,000 a discounted share price of £3.4733. Investors joining in for the remaining £200,000 thereafter will purchase a share for £4.6622. The funds raised will be used for further platform development, sales and marketing, and working capital.
days to go:
Expired
investment:
Withheld
Evolution Biotechnologies (EB) is a company that aims to bring technologies of biological control from their proven uses in agriculture into high-need and high-value biomedical markets. The company aims to curtail the spread of the house dust mite, a key cause of asthma, through its patented device. Its room treatment kit for domestic or commercial use contains natural agents that target the house dust mite in a highly specific way. The company anticipates that this method will be able to exert widespread, stable control across a whole room from limited initial applications, following a standard agricultural practice. EB expects a potential market size of $2 billion per annum in China, the UK, Europe, and the United States for its product. It is seeking an investment of £2 million to bring the aforementioned product to field trials.
days to go:
Expired
investment:
Withheld
epaysecure is a secure payment system, which offers comprehensive payment and benefit options, and allows all the services the consumer demands to be offered in one card and e-account. The prepaid business purchasing in European markets is estimated to be $700 million. The company operates in an e-banking and financial services marketing sector that helps clients by identifying new markets and bringing in new ideas to develop them through reloadable products and e-Wallet platform. The funds will be used for staffing, set up costs, other overheads including property marketing and general office costs.
days to go:
Expired
investment:
£168,340
End-to-end platform that enables content owners to profitably deliver video content direct-2-user in a complex multi-device world.
days to go:
Expired
investment:
£510,000
Doc2UK is a specialist UK medical recruitment and candidate support platform. Based in London, the platform places qualified doctors in the National Health Scheme (NHS) roles around the United Kingdom. The British Medical Association (2018) reported that patient care is at risk due to a critical shortage of doctors across multiple medical disciplines. At present, the UK only has 24 medical schools to fill this gap, whilst India, in comparison, has 468 medical schools, with 68,000 doctors graduating each year. Moreover, uncertainty about the status of EU nationals after Brexit, changes to immigration policies, and the impact of changing language testing requirements for international nurses have made this crisis worse. This situation necessitates recruiting doctors from overseas an important endeavour. This is where Doc2UK aims to become a key player and ensure that lack of medical personnel doesn't disrupt any medical services. The company is seeking an investment of up to £300,000 which will be used to develop the platform with more features, expand the team, marketing and sales.
days to go:
Expired
investment:
Withheld
